Cost Effectiveness of Rituximab Maintenance Therapy in Follicular Lymphoma: Long-Term Economic Evaluation

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.28, Iss.1, 2010-01, pp. : 35-46

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rituximab long-term efficacy for follicular lymphoma confirmed

Inpharma, Vol. 1, Iss. 1651, 2008-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

An Evaluation of the Cost-Effectiveness of Rituximab in Combination with Chemotherapy for the First-Line Treatment of Follicular Non-Hodgkin's Lymphoma in the UK

By Ray Joshua A. Carr Emma Lewis Gavin Marcus Robert

Value in Health, Vol. 13, Iss. 4, 2010-06 ,pp. : 346-357

Blackwell Publishing

Access to resources Recommend Favorite

Rituximab: As First-Line Maintenance Therapy Following Rituximab-Containing Therapy for Follicular Lymphoma

By Croxtall Jamie D.

Drugs, Vol. 71, Iss. 7, 2011-05 ,pp. : 885-895

Adis International

Access to resources Recommend Favorite

Rituximab maintenance improves outcomes in follicular lymphoma

Inpharma, Vol. 1, Iss. 1568, 2006-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Frontline rituximab monotherapy induction versus a watch and wait approach for asymptomatic advanced-stage follicular lymphoma: A cost-effectiveness analysis

By Prica Anca Chan Kelvin Cheung Matthew

Cancer, Vol. 121, Iss. 15, 2015-08 ,pp. : 2637-2645

Blackwell Publishing

Access to resources Recommend Favorite